Anthropic reports five cases of possible biological misuse
Anthropic · Company report
Read the source (opens in a new tab)- What happened
- Anthropic published five case studies of accounts using Claude in ways that could support biological weapons development, and banned the accounts it detected.
- Key points
- Anthropic says that, to its knowledge, no private company had yet publicly shared evidence of potential misuse of its platform for biological weapons development.
- In one case, Opus 5 drafted a complete orthopoxvirus immune-evasion grant application in about an hour for a reseller relay serving a dozen customers.
- Other cases involved chikungunya gain-of-function work, avian influenza mammalian-adaptation planning, a venom peptide pipeline, and computational toxin redesign for a national program.
- It says biology is dual use and sophisticated actors exploit that for "plausible deniability," hiding intent in requests that look beneficial.
- Evidence
- Company report on activity it detected on its own platform, within a threat report covering December 2025 to August 2026. It withholds the institutions and countries involved.
- Uncertain
- Anthropic says those implicated "are working scientists" and does "not assert that they intended harm." The page prints only "September 2026"; our day comes from its CMS timestamps and file names.